Daily Archives: Friday February 6th, 2015

Research Training at Department of Clinical Science

Roland JonssonOn an annual basis Department of Clinical Science has to report to the Faculty about what has been done to favour quality of the doctoral education and training for our 140-145 active PhD trainees. For 2013 we reported that the mandatory part of the UiB fellowships had to be checked up, on promotion of the research schools, to establish new research training courses and an increased focus on career planning and mobility of our candidates.     

Has this been followed up? Yes, to a major extent. The routines for handling the mandatory part (25%) of the UiB fellowships have been better organized. Regarding the research schools the new seminar series “Perspectives in translational medicine” has become a success with challenging and appealing lectures in the Bergen Postgraduate School of Clinical Medicine Research. And the Bergen Research School of Inflammation has established new courses (flowcytometry) and seen an increase in attendance at their immunology courses.

For the future it will also be a priority for both the PhD candidates and with the help from supervisors to plan the coming careers as well as increase the mobility e.g. visits with other groups/laboratories. Some of our candidates have got really interesting international visits, but this could have been much more implemented. It should also be emphasised that the research group leaders are encouraged to have meetings with the PhD candidates annually e.g. “medarbeidersamtaler” to pick up problems, misunderstandings etc. and not only the regular progress reports.

There has been no failure of PhD theses at Department of Clinical Science in 2014; a total of 23 candidates have finalized their theses with a public defence. Also the interaction between supervisors and PhD candidates has been smooth with only a few misunderstandings/problems, and these have been sorted out. So we are on the right track…….



Horizon2020 spotlight: COST Action – facts and chances

 What is COST?

COST is an intergovernmental framework for European Co-operation in Science and Technology. It funds pan-European, bottom-up networks, called ‘COST Actions’ of European researchers, engineers and scholars across all disciplines. Cost Actions are are open throughout their lifetime to new members and are adaptable in terms of internal organisation and strategy. These networks intend to coordinate nationally funded research activities throughout Europe, thereby reducing fragmentation of investment and contributing to the European Research Area (ERA) agenda. COST draws the funds for its activities from Horizon 2020, and the new strategy plan has much in common with H2020 goals. COST Actions are an instrument to close the gap between science, policy makers and society throughout Europe and beyond. COST funds networking activities; it does not fund research.

  Continue reading